Most 2026 NFL mock drafts explore what each team COULD do, but how about what everyone SHOULD do? Adam Rank simulates the ...

The NFL’s official simulation projects an aggressive first round, with quarterbacks reshaping the board and teams making bold ...

After a chaotic free agency period, the Minnesota Vikings turn their focus to the 2026 NFL Draft, where they will begin the night with nine picks to work with. Minnesota remains without a general ...

The Minnesota Vikings aggressively pursued veteran defensive linemen during the 2025 offseason. But the tactic didn’t work. The team parted ways with signees Javon Hargrave and Jonathan Allen before ...

The Minnesota Vikings are looking ahead to the 2025 NFL Draft. However, they have a ghost from the past that has officially reached its final form. Everyone in the Vikings’ fanbase is familiar with ...

The 2026 NFL Draft will take place in Pittsburgh next April, a city that could be where the Vikings select the next star they add to their roster in hopes of righting the proverbial ship. Before next ...

# LICENSE file in the root directory of this source tree. Script for training, evaluating, and running model model chats for Task Oriented Dialog. from parlai.scripts.tod_world_script import ...

An independent researcher believes he’s discovered a legendary ruler’s burial site — a find that could be the first monumental Viking ship burial identified in England. Steve Dickinson, a British ...

Where will Green Bay Packers backup quarterback and soon-to-be free agent Malik Willis end up in 2026? ESPN set out to find a potential answer before the start of free agency, using a group of ...

The Vikings are "now open" to the idea of trading Pro Bowl outside linebacker Jonathan Greenard, according to a report from ESPN's Adam Schefter on Tuesday. "They would like to keep Greenard, but they ...

Viking Therapeutics is working to join a market that may be worth almost $100 billion in just a few years. The company is studying a candidate for weight loss in late-stage trials. But those pharma ...